TRPV4 dysfunction promotes renal cystogenesis in autosomal recessive polycystic kidney disease.
about
ChannelopathiesPathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapyMegalencephalic leukoencephalopathy with subcortical cysts protein-1 modulates endosomal pH and protein trafficking in astrocytes: relevance to MLC disease pathogenesisDeciphering physiological role of the mechanosensitive TRPV4 channel in the distal nephron.Emerging role of the calcium-activated, small conductance, SK3 K+ channel in distal tubule function: regulation by TRPV4Molecular pathways and therapies in autosomal-dominant polycystic kidney diseaseFlow stimulated endocytosis in the proximal tubule.Vasopressin and disruption of calcium signalling in polycystic kidney disease.Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium.Activation of transient receptor potential vanilloid-1 (TRPV1) influences how retinal ganglion cell neurons respond to pressure-related stress.Role of renal TRP channels in physiology and pathologyDiscrete control of TRPV4 channel function in the distal nephron by protein kinases A and C.Defective Store-Operated Calcium Entry Causes Partial Nephrogenic Diabetes InsipidusTRPV4 channels regulate tumor angiogenesis via modulation of Rho/Rho kinase pathwayFlow-induced activation of TRPV5 and TRPV6 channels stimulates Ca(2+)-activated K(+) channel causing membrane hyperpolarization.Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.Developmental signaling: does it bridge the gap between cilia dysfunction and renal cystogenesis?TRPV4: physiological role and therapeutic potential in respiratory diseases.Therapeutic targets for polycystic kidney disease.TRPV4 channels: physiological and pathological role in cardiovascular system.Functional and therapeutic importance of purinergic signaling in polycystic kidney disease.Renoprotection: focus on TRPV1, TRPV4, TRPC6 and TRPM2.Primary Cilia in Cystic Kidney Disease.TRPV4 channel activation selectively inhibits tumor endothelial cell proliferationThe renal TRPV4 channel is essential for adaptation to increased dietary potassium.Deficient transient receptor potential vanilloid type 4 function contributes to compromised [Ca2+]i homeostasis in human autosomal-dominant polycystic kidney disease cells.Pathways, perspectives and pursuits in polycystic kidney disease.
P2860
Q24601791-DFAADF44-4950-4AD8-AAA1-2879412B7039Q27000075-4F67F72D-94EC-434A-9097-852F0DB150AAQ30577254-F0119129-6236-42A1-8B7F-DFCD4075DFF4Q35086473-397D2C7A-24EB-47FB-8C87-D8FFC2A92876Q35156822-6D374629-C8A9-4562-9F1C-2972506706BAQ35578646-FB95700B-0D96-4F02-9DB3-CEC53ED15D9FQ35828297-5EAB93DE-2AAC-4729-8D9B-0D019D298DD3Q35962991-CAE1E348-2C0A-4729-B825-ACB677AF0E47Q36089601-248FBC6D-5109-4FA4-9C6D-5922BE38E7BAQ36124954-C5A6D82D-C053-4388-81D3-89AFDE28507AQ36703547-597867B2-CE1C-4210-9D2A-4685A0DB8B1EQ37012415-E07D9BD9-778C-4AE2-B34F-884DD3AB6053Q37051972-C4A11C41-52CE-47F3-AC96-AB579439F1EFQ37295520-6ECDECC8-A5AB-4CA2-AA49-A366BE0C5FC5Q37598664-9042C92C-CE1C-432C-8634-344767F47BB2Q38171193-2F8A45BD-45F6-400A-A7FB-15BB48EE99B5Q38214832-3886409F-36C3-4A8E-B8BE-D4A87B624DA0Q38262420-F2D552C6-CD86-4D81-A048-1C339AF23A41Q38578289-B1F75E09-03BF-4972-884A-F18DF22035E9Q38594754-8A4CE91D-3DD7-490C-81F4-B9A93DA66573Q38961131-6821AC60-DB74-4468-A228-5C5C6A3813C6Q39060342-D1244E0A-FABD-4C7E-A729-576AB64E3C73Q39242476-452D4981-4F07-48A4-97AE-9AC95B1A2DFBQ41813544-B84582CB-CCFD-4CA1-9472-2989A6A4A155Q51141779-9EB5D32E-F71D-4BE5-8523-D224922F6286Q52689816-B35524F2-B5C1-4941-821D-4301C2DE33FCQ53958174-4F28355D-4BEA-46BC-88C0-F3462D6076E6
P2860
TRPV4 dysfunction promotes renal cystogenesis in autosomal recessive polycystic kidney disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
TRPV4 dysfunction promotes ren ...... ive polycystic kidney disease.
@ast
TRPV4 dysfunction promotes ren ...... ive polycystic kidney disease.
@en
type
label
TRPV4 dysfunction promotes ren ...... ive polycystic kidney disease.
@ast
TRPV4 dysfunction promotes ren ...... ive polycystic kidney disease.
@en
prefLabel
TRPV4 dysfunction promotes ren ...... ive polycystic kidney disease.
@ast
TRPV4 dysfunction promotes ren ...... ive polycystic kidney disease.
@en
P2093
P2860
P356
P1476
TRPV4 dysfunction promotes ren ...... ive polycystic kidney disease.
@en
P2093
Jonathan Berrout
Mykola Mamenko
Nabila Boukelmoune
Oleg Zaika
Oleh Pochynyuk
Roger G O'Neil
P2860
P304
P356
10.1681/ASN.2012050442
P577
2013-02-14T00:00:00Z